Alyeska Investment Group’s LENZ Therapeutics LENZ Stock Holding History

Alyeska Investment Group’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Sell	438,882 -24,613	-5%	-$198K	0.01%	559
2026 Q1	$4.24M	Hold	463,495	–	–	0.01%	492
2025 Q4	$7.42M	Buy	463,495 +221,382	+91%	+$6.45M	0.02%	426
2025 Q3	$11.3M	Buy	242,113 +25,000	+12%	+$919K	0.03%	359
2025 Q2	$6.36M	Buy	217,113 +75,000	+53%	+$2.04M	0.02%	396
2025 Q1	$3.65M	Hold	142,113	–	–	0.01%	382
2024 Q4	$4.1M	Buy	142,113 +20,000	+16%	+$610K	0.02%	409
2024 Q3	$2.9M	Sell	122,113 -199,602	-62%	-$4.43M	0.01%	391
2024 Q2	$5.56M	Buy	321,715 +122,113	+61%	+$2.13M	0.03%	324
2024 Q1	$4.43M	Buy	+199,602	New	+$4.15M	0.03%	336
2021 Q3	–	Sell	-4,286	Closed	-$922K	–	814
2021 Q2	$922K	Buy	+4,286	New	+$747K	0.01%	614

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Alyeska Investment Group's LENZ Position: Q2 2026 in Review

Alyeska Investment Group reduced its LENZ Therapeutics (LENZ) stake by 5.3% in Q2 2026, selling an estimated $198K and leaving 438,882 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #559.

Alyeska Investment Group first reported a position in LENZ in Q2 2021 and has held it in 11 quarters since. The position peaked at $11.3M in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Alyeska Investment Group held 438,882 shares of LENZ Therapeutics worth $2.49M as of Q2 2026.
Alyeska Investment Group sold 24,613 LENZ Therapeutics shares in Q2 2026, an estimated $198K.
LENZ Therapeutics made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #559 holding.
Alyeska Investment Group first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 11 quarters since.
Alyeska Investment Group's LENZ Therapeutics position peaked at $11.3M in Q3 2025.
144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.